Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis
- PMID: 16968893
- DOI: 10.1182/blood-2006-07-033985
Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis
Abstract
Lymphomagenesis in Emu-Myc mice is opposed by the Arf tumor suppressor, whose inactivation compromises p53 function and accelerates disease. Finding nascent Emu-Myc-induced tumors in which p19Arf causes cell-cycle arrest or apoptosis is problematic, since such cells will be eliminated until Arf or p53 function is lost. Knock-in mice expressing a green fluorescent protein (GFP) in lieu of Arf coding sequences allow analysis of Arfpromoter regulation uncoupled from p19Arf action. Prior to frank lymphoma development, unexpectedly low levels of Emu-Myc-induced p19Arf or GFP were expressed. However, as lymphomas arose in Arf+/GFP heterozygotes, additional oncogenic events synergized with Emu-Myc to further induce the functionally null Arf-Gfp allele. Concomitant up-regulation of p19Arf was not observed; instead, the wild-type allele was inactivated. We infer that very low levels of Arf are tumor suppressive, and that further induction provides the selective pressure for the emergence of tumors that have inactivated the gene.
Similar articles
-
Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.Oncogene. 2015 Nov 12;34(46):5709-17. doi: 10.1038/onc.2015.39. Epub 2015 Mar 30. Oncogene. 2015. PMID: 25823025 Free PMC article.
-
Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.Oncogene. 2004 Nov 25;23(55):8931-40. doi: 10.1038/sj.onc.1208052. Oncogene. 2004. PMID: 15467748
-
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.Genes Dev. 1999 Oct 15;13(20):2658-69. doi: 10.1101/gad.13.20.2658. Genes Dev. 1999. PMID: 10541552 Free PMC article.
-
The Myc-nucleophosmin-ARF network: a complex web unveiled.Cell Cycle. 2009 Sep 1;8(17):2703-7. doi: 10.4161/cc.8.17.9418. Epub 2009 Sep 2. Cell Cycle. 2009. PMID: 19652540 Free PMC article. Review.
-
p53-Dependent and -independent functions of the Arf tumor suppressor.Cold Spring Harb Symp Quant Biol. 2005;70:129-37. doi: 10.1101/sqb.2005.70.004. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869746 Review.
Cited by
-
Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.J Clin Invest. 2008 Jan;118(1):51-63. doi: 10.1172/JCI33320. J Clin Invest. 2008. PMID: 18060046 Free PMC article.
-
The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.PLoS Pathog. 2012;8(12):e1003084. doi: 10.1371/journal.ppat.1003084. Epub 2012 Dec 13. PLoS Pathog. 2012. PMID: 23271972 Free PMC article.
-
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.Genes Dev. 2007 Nov 1;21(21):2775-87. doi: 10.1101/gad.453107. Genes Dev. 2007. PMID: 17974917 Free PMC article.
-
Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.Cancer Res. 2010 Nov 15;70(22):9084-94. doi: 10.1158/0008-5472.CAN-10-0159. Epub 2010 Nov 9. Cancer Res. 2010. PMID: 21062982 Free PMC article.
-
Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development.Development. 2009 Jun;136(12):2081-9. doi: 10.1242/dev.033548. Development. 2009. PMID: 19465598 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
